Clarification sought from Lupin

29 Mar 2016 Evaluate

The Exchange has sought clarification from Lupin with reference to the news flashed on CNBC TV 18 ‘Mandideep unit inspected by US FDA from 8-19 Feb 2016. US FDA observations at Mandideep unit are serious in nature and the unit gets 483 letter’.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2331.75 34.55 (1.50%)
24-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1752.80
Dr. Reddys Lab 1259.60
Cipla 1219.30
Zydus Lifesciences 886.50
Lupin 2331.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×